Brief Title
Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study
Official Title
Zenith® Fenestrated AAA Endovascular Graft Clinical Study
Brief Summary
The Zenith®Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.
Study Type
Expanded Access
Condition
Abdominal Aortic Aneurysms
Intervention
Zenith® Fenestrated AAA Endovascular Graft
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Device
Eligibility Criteria
Inclusion Criteria: - Abdominal aortic and aortoiliac aneurysms with diameter greater than or equal to 5 cm Exclusion Criteria: - Proximal neck less than 4 mm or greater than or equal to 15 mm in length unless otherwise compromised to preclude seal - Renal artery stenosis greater than 50 percent
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
, ,
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT02577562
Organization ID
04-541 CA
Responsible Party
Sponsor
Study Sponsor
Cook Group Incorporated
Study Sponsor
, ,
Verification Date
November 2017